CD30 Recombinant Rabbit mAb (SDT-216-2)

產(chǎn)品型號(hào)：S0B2183

更新時(shí)間：2025-10-09

廠(chǎng)商性質(zhì)：生產(chǎn)廠(chǎng)家

訪(fǎng)問(wèn)量：80

服務(wù)熱線(xiàn)

15855403091

立即咨詢(xún)

產(chǎn)品分類(lèi)

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

癌癥治療新紀(jì)元：ADC藥物如何以“精準(zhǔn)制導(dǎo)+超級(jí)彈頭“改寫(xiě)抗癌規(guī)則？

成纖維細(xì)胞生長(zhǎng)因子21：代謝調(diào)控的新星與治療前沿

GFAP Mouse mAb的應(yīng)用領(lǐng)域有哪些？

產(chǎn)品介紹

CD30 is a transmembrane protein from the tumour necrosis factor receptor superfamily. It is expressed on a small subset of activated T and B lymphocytes, and various lymphoid neoplasms. CD30 is a particularly treatment target because its levels are high in tumours but low in healthy tissues. Several therapeutic strategies targeting CD30 have been developed, including monoclonal antibodies, conjugated antibodies （combination of brentuximab vedotin with chemotherapy or immunotherapy）, bispecific antibodies and cell and gene therapies, such as anti-CD30 CAR-T cells in particular [PMID: 37170397

].

上一個(gè)：S0B2182SOX9 Recombinant Rabbit mAb (SDT-019-29)